<HTML>
<HEAD>
   <TITLE>v03570_s8</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">
<p align="center"><A name="page_1"></A> <FONT size=2 face="serif">As filed with the Securities and Exchange Commission on May 20, 2004.</FONT></p>
<div align="right"><FONT size=2 face="serif">Registration No. 333-_____ </FONT> </div>
<hr align="right" size="1" noshade color="#000000">
<hr align="right" size="1" noshade color="#000000">
<P align="center"><FONT size=2 face="serif">UNITED STATES<br>
  </FONT><FONT size=2 face="serif">SECURITIES AND EXCHANGE COMMISSION<br>
  </FONT><FONT size=2 face="serif">WASHINGTON, DC 20549 </FONT></p>
<hr align="center" width="125" size="1" noshade>
<P align="center"> <B><FONT size=2 face="serif">FORM S-8<br>
  </FONT></B><B><FONT size=2 face="serif">REGISTRATION STATEMENT<br>
  </FONT></B><B><FONT size=2 face="serif">UNDER<br>
  </FONT></B><B><FONT size=2 face="serif">THE SECURITIES ACT OF 1933</FONT></B></P>
<hr align="center" width="125" size="1" noshade>
<P align="center"><FONT size=5 face="serif"><strong>Nabi Biopharmaceuticals</strong></FONT><FONT size=6 face="serif"><br>
  </FONT><FONT size=1 face="serif">(Exact Name of Registrant as Specified in its Charter) </FONT></p>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">Delaware</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">59-1212264</FONT></TD></tr>
  <TR align="center">
    <TD width="50%">
<hr width="40%" size="1" noshade></TD>
    <TD width="50%">
<hr width="40%" size="1" noshade></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=1 face="serif">(State or Other Jurisdiction of</FONT></TD>
    <TD width="50%"><FONT size=1 face="serif">(I.R.S. Employer</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=1 face="serif">Incorporation or Organization)</FONT></TD>
    <TD width="50%"><FONT size=1 face="serif">Identification No.)</FONT></TD></tr>
</TABLE>
<P align="center"> <FONT size=2 face="serif">5800 Park of Commerce Boulevard, N.W.<br>
  </FONT><FONT size=2 face="serif">Boca Raton, FL 33487<br>
  </FONT><FONT size=1 face="serif">(Address of Principal Executive Offices, Including Zip Code)</FONT></P>
<hr align="center" width="125" size="1" noshade>
<P align="center"> <FONT size=2 face="serif">Nabi 2000 Equity Incentive Plan<br>
  </FONT><FONT size=1 face="serif">(Full Title of the Plan) </FONT></p>
<hr align="center" width="125" size="1" noshade>
<FONT size=2 face="serif"><BR>
</FONT>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">Thomas H. McLain</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">Copies to:</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">Nabi Biopharmaceuticals</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">James E. Dawson, Esq.</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">5800 Park of Commerce Boulevard, N.W.</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">Kevin T. Sheehan, Esq.</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">Boca Raton, FL 33487</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">Nutter, McClennen &amp; Fish, LLP</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=2 face="serif">(561) 989-5800</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">155 Seaport Boulevard</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=1 face="serif">(Name, Address, and Telephone Number,</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">Boston, MA 02210-2604</FONT></TD></tr>
  <TR align="center">
    <TD width="50%"><FONT size=1 face="serif">Including Area Code, of Agent for Service)</FONT></TD>
    <TD width="50%"><FONT size=2 face="serif">(617) 439-2000</FONT></TD></tr>
</TABLE>
<br>
<hr align="center" width="125" size="1" noshade>
<P align="center"><B><FONT size=2 face="serif">CALCULATION OF REGISTRATION FEE</FONT></B></p>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR>
    <TD width="100%"><FONT size=2 face="serif">Title of Each Class of<br>
      Securities to be Registered</FONT></TD>
    <TD align="center" nowrap><FONT size=2 face="serif">Amount to be<br>
      Registered</FONT></TD>
    <TD align="center" nowrap><font size="2">&nbsp;</font></TD>
    <TD align="center" nowrap><FONT size=2 face="serif">Proposed Maximum<br>
      Offering Price per Share</FONT></TD>
    <TD align="center" nowrap><font size="2">&nbsp;</font></TD>
    <TD align="center" nowrap><FONT size=2 face="serif">Proposed Maximum<br>
      Aggregate Offering Price</FONT></TD>
    <TD align="center" nowrap><font size="2">&nbsp;</font></TD>
    <TD align="center" nowrap><FONT size=2 face="serif">Amount of<br>
      Registration Fee</FONT></TD></tr>
  <TR>
    <TD width="100%"> <HR align="left" width="155" size=1 noshade></TD>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD><HR noshade size=1></TD></tr>
  <TR bgcolor="#66FF99">
    <TD width="100%"><FONT size=2 face="serif">Common Stock, par value $.10 per share (1)</FONT></TD>
    <TD align="center" nowrap><FONT size=2 face="serif">4,500,000 shares (2)</FONT></TD>
    <TD align="center"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></TD>
    <TD align="center"><FONT size=2 face="serif">$16.095(3)</FONT></TD>
    <TD align="center"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></TD>
    <TD align="center"><FONT size=2 face="serif">$72,427,500(3)</FONT></TD>
    <TD align="center"><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></TD>
    <TD align="center"><FONT size=2 face="serif">$9,176.56</FONT></TD></tr>
  <TR>
    <TD width="100%"> <HR align="left" width="100" size=1 noshade></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
</TABLE>
<TABLE border="0" cellpadding="0" cellspacing="0">
  <TR>
    <TD valign="top" width="5%"><FONT size=2 face="serif">(1)</FONT><font size="2"><BR>
      &nbsp;&nbsp;</font></TD>
    <TD valign="top"><FONT size=2 face="serif">This registration statement also relates to rights to purchase shares of Series One Preferred
      Stock. The rights are attached to the Common Stock and are issued pursuant to the terms of the registrant&#146;s Rights Agreement
      dated August 1, 1997, as amended. Until the occurrence of certain events, the rights will not be exercisable and will be transferable
      with and only with the Common Stock. Because no separate consideration is to be paid for the rights, the registration fee for the
      rights is included in the registration fee for the Common Stock.<BR>
      &nbsp;</FONT></TD></tr>
  <TR>
    <TD valign="top" width="5%"><FONT size=2 face="serif">(2)</FONT><font size="2"><BR>
      &nbsp;&nbsp;</font></TD>
    <TD valign="top"><FONT size=2 face="serif">This registration statement covers up to 4,500,000 shares of Common Stock that may be issued
      under the registrant&#146;s 2000 Equity Incentive Plan. This registration statement also covers an indeterminate number of shares
      that may become issuable under the Plan as a result of a stock dividend, stock split, or other recapitalization.<BR>
      &nbsp;</FONT></TD></tr>
  <TR>
    <TD valign="top" width="5%"><FONT size=2 face="serif">(3)</FONT><font size="2"><BR>
      &nbsp;&nbsp;</font></TD>
    <td valign="top"><FONT size=2 face="serif">Estimated solely for the purpose of calculating the registration fee pursuant to Rules
      457(c) and (h) under the Securities Act of 1933, as amended, based on the average of the high and low sale prices per share of the
      Common Stock as reported on The Nasdaq National Market on May 17, 2004.<BR>
      &nbsp;</FONT></TD></tr>
</TABLE>

<hr align="right" size="1" noshade color="#000000">
<hr align="right" size="1" noshade color="#000000">
<br>
<HR noshade style="PAGE-BREAK-AFTER: always" align="center" width="100%" color="#33FF99" size=1>


<A name="page_2"></A>

<P align="center">
<B><FONT size=2 face="serif">REGISTRATION OF ADDITIONAL SECURITIES </FONT></B></p>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">On February 12, 2004, the board of directors of Nabi Biopharmaceuticals, a Delaware corporation (the &#147;Company&#148;), amended the Company&#146;s 2000 Equity Incentive Plan (the
&#147;Plan&#148;), subject to the approval of the stockholders of the Company, to increase the number of shares of the Company&#146;s common stock, par value $.10 per share (the &#147;Common Stock&#148;), that may be issued under the Plan from
1,196,922 to 6,196,922. On May 14, 2004, the stockholders of the Company approved the amendment. The Company is filing this registration statement to register the issuance of up to 4,500,000 additional shares of Common Stock that may be issued under
the Plan as a result of the amendment. Pursuant to General Instruction E to Form S-8, the contents of the Company&#146;s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 8, 2000 (File No. 333-38864) are
incorporated by reference into this registration statement. </FONT></p>

<HR noshade style="PAGE-BREAK-AFTER: always" align="center" width="100%" color="#33FF99" size=1>


<A name="page_3"></A>

<P align="center">
<B><FONT size=2 face="serif">SIGNATURES </FONT></B></p>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on
Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on May 20, 2004. </FONT></p>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
  <TR>
    <TD width="46%">&nbsp;</TD>
    <TD colspan="2"><FONT size=2 face="serif">NABI BIOPHARMACEUTICALS</FONT></TD></tr>
  <TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="52%">&nbsp;</TD></tr>
  <TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="2%"><FONT size=2 face="serif">By:</FONT>&nbsp;</TD>
    <TD width="52%"><FONT size=2 face="serif">/s/ Thomas H. McLain</FONT></TD></tr>
  <TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD colspan=1><HR noshade size=1></TD></tr>
  <TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="52%"><FONT size=2 face="serif">Thomas H. McLain<br>
      &nbsp;<FONT size=2 face="serif">Chief Executive Officer, President, and Chairman of the Board</FONT> </FONT></TD>
  </tr>
</TABLE>
<P align="center">
<B><FONT size=2 face="serif">POWER OF ATTORNEY </FONT></B></p>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Thomas H. McLain, Mark L. Smith, Constantine Alexander, and James E. Dawson, and each
of them, with full power to act without the others, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in his or her name, place and stead, in any and all
capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary or advisable to be done in connection therewith, as fully to all intents and purposes as he or she
might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </FONT></p>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </FONT></p>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR>
    <TD width="32%"><U><FONT size=2 face="serif">Signature</FONT></U></TD>
    <TD align="center">&nbsp;</TD>
    <TD width="45%" align="center"><U><FONT size=2 face="serif">Title</FONT></U></TD>
    <TD width="22%" align="center" nowrap><U><FONT size=2 face="serif">Date</FONT></U></TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">/s/ Thomas H. McLain</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Chief Executive Officer, President, and</FONT></TD>
    <TD width="22%" align="center" nowrap><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD width="32%"> <HR noshade size=1></TD>
    <TD nowrap>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Chairman of the Board (principal executive officer)</FONT></TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">Thomas H. McLain</FONT></TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">/s/ Mark L. Smith</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Senior Vice President, Finance, Chief</FONT></TD>
    <TD width="22%" align="center" nowrap><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD width="32%"> <HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Financial Officer, Chief Accounting</FONT></TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">Mark L. Smith</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Officer, and Treasurer (principal</FONT></TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">financial and accounting officer)</FONT></TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">/s/ David L. Castaldi</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD width="22%" align="center" nowrap><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD width="32%"> <HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">David L. Castaldi</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">/s/ Geoffrey F. Cox, Ph.D.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD width="22%" align="center" nowrap><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD width="32%"> <HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">Geoffrey F. Cox, Ph.D.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">/s/ George W. Ebright</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD width="22%" align="center" nowrap><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD width="32%"> <HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD width="32%"><FONT size=2 face="serif">George W. Ebright</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%" nowrap>&nbsp;</TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center">&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">/s/ Richard A. Harvey, Jr.</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD align="center" width="22%"><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">Richard A. Harvey, Jr.</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">/s/ Linda Jenckes</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD align="center" width="22%"><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">Linda Jenckes</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">/s/ Stephen G. Sudovar</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%"><FONT size=2 face="serif">Director</FONT></TD>
    <TD align="center" width="22%"><FONT size=2 face="serif">May 20, 2004</FONT></TD></tr>
  <TR>
    <TD><HR noshade size=1></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">Stephen G. Sudovar</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD></tr>
</TABLE>
<P align="center"> <FONT size=2 face="serif">- 3 -</FONT></p>

<HR noshade style="PAGE-BREAK-AFTER: always" align="center" width="100%" color="#33FF99" size=1>


<A name="page_5"></A>

<P align="center">
<B><FONT size=2 face="serif">EXHIBIT INDEX </FONT></B></p>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
  <TR>
    <TD align="center" nowrap><U><FONT size=2 face="serif">Exhibit No</FONT></U><FONT size=2 face="serif">.</FONT></TD>
    <TD align="center">&nbsp;</TD>
    <TD width="100%" align="center"><U><FONT size=2 face="serif">Description</FONT></U></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Form of Common Stock Certificate (incorporated by reference to Exhibit 4.4 to the</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Company&#146;s Current Report on Form 8-K filed on August 21, 1997).</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">4.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Rights Agreement dated August 1, 1997, between the Company and Registrar and</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Transfer Company, as amended (incorporated by reference to Exhibit 10.28 to the</FONT></TD></tr>
  <TR>
    <TD height="20">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Company&#146;s Annual Report on Form 10-K for the year ended December 31, 1997).</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Agreement of Substitution and Amendment of Rights Agreement dated July 1, 2002,</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">among the Company, Registrar and Transfer Company, and American Stock Transfer</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">&amp; Trust Company (incorporated by reference to Exhibit 4.4 to the Company&#146;s Annual</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Report on Form 10-K for the year ended December 28, 2002).</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Opinion of Nutter, McClennen &amp; Fish, LLP.</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">23.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Consent of Nutter, McClennen &amp; Fish, LLP (contained in Exhibit 5).</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">23.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Consent of Ernst &amp; Young LLP, independent certified public accountants.</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">24</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Power of Attorney (included on signature page).</FONT></TD></tr>
  <TR>
    <TD><FONT size=2 face="serif">99</FONT></TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Nabi 2000 Equity Incentive Plan, as amended (incorporated by reference to the</FONT></TD></tr>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD width="100%"><FONT size=2 face="serif">Company&#146;s Definitive Proxy Statement filed under cover of Schedule 14A on April 9,
      2004). </FONT></TD></tr>
</TABLE>
<p align="center"><FONT size=2 face="serif">- 4 -</FONT></p>
<HR noshade align="center" width="100%" color="#33FF99" size=1>
<P align="center">&nbsp; </p>

</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "v03570_s8.htm", "secsgml_size_bytes": 22729}]
{"company-data": {"conformed-name": "NABI  BIOPHARMACEUTICALS", "cik": "0000072444", "assigned-sic": "2836", "irs-number": "591212264", "state-of-incorporation": "DE", "fiscal-year-end": "1225"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-115688", "film-number": "04821850"}, "business-address": {"street1": "5800 PARK OF COMMERCE BLVD N W", "street2": "STE 322", "city": "BOCA RATON", "state": "FL", "zip": "33487", "phone": "5619895800"}, "mail-address": {"street1": "5800 PARK OF COMMERCE BLVD NW", "street2": "STE 322", "city": "BOCA RATON", "state": "FL", "zip": "33487"}, "former-company": [{"former-conformed-name": "NABI /DE/", "date-changed": "19960405"}, {"former-conformed-name": "NORTH AMERICAN BIOLOGICALS INC", "date-changed": "19920703"}]}
v03570_s8
As filed with the Securities and Exchange Commission on May 20, 2004.
Registration No. 333-_____
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Nabi Biopharmaceuticals
(Exact Name of Registrant as Specified in its Charter)
Delaware
59-1212264
(State or Other Jurisdiction of
(I.R.S. Employer
Incorporation or Organization)
Identification No.)
5800 Park of Commerce Boulevard, N.W.
Boca Raton, FL 33487
(Address of Principal Executive Offices, Including Zip Code)
Nabi 2000 Equity Incentive Plan
(Full Title of the Plan)
Thomas H. McLain
Copies to:
Nabi Biopharmaceuticals
James E. Dawson, Esq.
5800 Park of Commerce Boulevard, N.W.
Kevin T. Sheehan, Esq.
Boca Raton, FL 33487
Nutter, McClennen & Fish, LLP
(561) 989-5800
155 Seaport Boulevard
(Name, Address, and Telephone Number,
Boston, MA 02210-2604
Including Area Code, of Agent for Service)
(617) 439-2000
CALCULATION OF REGISTRATION FEE
Title of Each Class of
Securities to be Registered
Amount to be
Registered
Proposed Maximum
Offering Price per Share
Proposed Maximum
Aggregate Offering Price
Amount of
Registration Fee
Common Stock, par value $.10 per share (1)
4,500,000 shares (2)
$16.095(3)
$72,427,500(3)
$9,176.56
(1)
This registration statement also relates to rights to purchase shares of Series One Preferred
      Stock. The rights are attached to the Common Stock and are issued pursuant to the terms of the registrant's Rights Agreement
      dated August 1, 1997, as amended. Until the occurrence of certain events, the rights will not be exercisable and will be transferable
      with and only with the Common Stock. Because no separate consideration is to be paid for the rights, the registration fee for the
      rights is included in the registration fee for the Common Stock.
(2)
This registration statement covers up to 4,500,000 shares of Common Stock that may be issued
      under the registrant's 2000 Equity Incentive Plan. This registration statement also covers an indeterminate number of shares
      that may become issuable under the Plan as a result of a stock dividend, stock split, or other recapitalization.
(3)
Estimated solely for the purpose of calculating the registration fee pursuant to Rules
      457(c) and (h) under the Securities Act of 1933, as amended, based on the average of the high and low sale prices per share of the
      Common Stock as reported on The Nasdaq National Market on May 17, 2004.
REGISTRATION OF ADDITIONAL SECURITIES
On February 12, 2004, the board of directors of Nabi Biopharmaceuticals, a Delaware corporation (the "Company"), amended the Company's 2000 Equity Incentive Plan (the
"Plan"), subject to the approval of the stockholders of the Company, to increase the number of shares of the Company's common stock, par value $.10 per share (the "Common Stock"), that may be issued under the Plan from
1,196,922 to 6,196,922. On May 14, 2004, the stockholders of the Company approved the amendment. The Company is filing this registration statement to register the issuance of up to 4,500,000 additional shares of Common Stock that may be issued under
the Plan as a result of the amendment. Pursuant to General Instruction E to Form S-8, the contents of the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 8, 2000 (File No. 333-38864) are
incorporated by reference into this registration statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on
Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boca Raton, State of Florida, on May 20, 2004.
NABI BIOPHARMACEUTICALS
By:
/s/ Thomas H. McLain
Thomas H. McLain
Chief Executive Officer, President, and Chairman of the Board
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Thomas H. McLain, Mark L. Smith, Constantine Alexander, and James E. Dawson, and each
of them, with full power to act without the others, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in his or her name, place and stead, in any and all
capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing necessary or advisable to be done in connection therewith, as fully to all intents and purposes as he or she
might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Thomas H. McLain
Chief Executive Officer, President, and
May 20, 2004
Chairman of the Board (principal executive officer)
Thomas H. McLain
/s/ Mark L. Smith
Senior Vice President, Finance, Chief
May 20, 2004
Financial Officer, Chief Accounting
Mark L. Smith
Officer, and Treasurer (principal
financial and accounting officer)
/s/ David L. Castaldi
Director
May 20, 2004
David L. Castaldi
/s/ Geoffrey F. Cox, Ph.D.
Director
May 20, 2004
Geoffrey F. Cox, Ph.D.
/s/ George W. Ebright
Director
May 20, 2004
George W. Ebright
/s/ Richard A. Harvey, Jr.
Director
May 20, 2004
Richard A. Harvey, Jr.
/s/ Linda Jenckes
Director
May 20, 2004
Linda Jenckes
/s/ Stephen G. Sudovar
Director
May 20, 2004
Stephen G. Sudovar
- 3 -
EXHIBIT INDEX
Exhibit No
.
Description
4.1
Form of Common Stock Certificate (incorporated by reference to Exhibit 4.4 to the
Company's Current Report on Form 8-K filed on August 21, 1997).
4.2
Rights Agreement dated August 1, 1997, between the Company and Registrar and
Transfer Company, as amended (incorporated by reference to Exhibit 10.28 to the
Company's Annual Report on Form 10-K for the year ended December 31, 1997).
4.3
Agreement of Substitution and Amendment of Rights Agreement dated July 1, 2002,
among the Company, Registrar and Transfer Company, and American Stock Transfer
& Trust Company (incorporated by reference to Exhibit 4.4 to the Company's Annual
Report on Form 10-K for the year ended December 28, 2002).
5
Opinion of Nutter, McClennen & Fish, LLP.
23.1
Consent of Nutter, McClennen & Fish, LLP (contained in Exhibit 5).
23.2
Consent of Ernst & Young LLP, independent certified public accountants.
24
Power of Attorney (included on signature page).
99
Nabi 2000 Equity Incentive Plan, as amended (incorporated by reference to the
Company's Definitive Proxy Statement filed under cover of Schedule 14A on April 9,
      2004).
- 4 -